Literature DB >> 17572869

[Daily problems involving contact with terminally ill patients with renal failure].

M J Moeller1, S Heidenreich, U Gladziwa, J Floege.   

Abstract

Practitioners and physicians working in emergency rooms are often confronted with dialysis patients or patients who have received a kidney transplant. For dialysis patients, the mode of dialysis treatment needs to be assessed and dialysis access should be secured. Furthermore, the indications for the next dialysis treatment need to be determined. Dialysis patients often present themselves because of fluid overload, hypo- or hypertensive episodes, electrolyte disturbances, fever or cardiovascular events. Patients undergoing continuous peritoneal dialysis are at an increased risk of infection of the catheter or of peritonitis. Patients with a renal transplant require continuation of their immunosuppression and the function of the transplant should be monitored. These patients often present with infections in which case the degree of immunosuppression may need to be reduced. Vaccinations as well as an increased risk for malignancies require special attention in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17572869     DOI: 10.1007/s00108-007-1888-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  11 in total

1.  Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update.

Authors:  W F Keane; G R Bailie; E Boeschoten; R Gokal; T A Golper; C J Holmes; Y Kawaguchi; B Piraino; M Riella; S Vas
Journal:  Perit Dial Int       Date:  2000 Jul-Aug       Impact factor: 1.756

2.  B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison.

Authors:  Christian Mueller; Kirsten Laule-Kilian; André Scholer; Charly Nusbaumer; Thomas Zeller; Daniel Staub; André P Perruchoud
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

Review 3.  Infection in organ-transplant recipients.

Authors:  J A Fishman; R H Rubin
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

4.  Subcutaneous terbutaline use in CKD to reduce potassium concentrations.

Authors:  Kevin M Sowinski; Donald Cronin; Bruce A Mueller; Michael A Kraus
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

5.  The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.

Authors:  C D Wimmer; M Rentsch; A Crispin; W D Illner; H Arbogast; C Graeb; K-W Jauch; M Guba
Journal:  Kidney Int       Date:  2007-02-28       Impact factor: 10.612

Review 6.  The use of vaccines in adult patients with renal disease.

Authors:  Mara Dinits-Pensy; Graeme N Forrest; Alan S Cross; Michael K Hise
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

Review 7.  Dialysis catheter-related bacteremia: treatment and prophylaxis.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

Review 8.  Care of the end-stage renal disease patient on dialysis in the ED.

Authors:  Arvind Venkat; Kristiana R Kaufmann; Kk Venkat
Journal:  Am J Emerg Med       Date:  2006-11       Impact factor: 2.469

Review 9.  Treatment of acute coronary syndromes in patients who have chronic kidney disease.

Authors:  Rory O'Hanlon; Donal N Reddan
Journal:  Med Clin North Am       Date:  2005-05       Impact factor: 5.456

Review 10.  Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency.

Authors:  Chidambaram Rammohan; Dan Fintel
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.